Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
BPC-157 works through at least five confirmed molecular mechanisms: eNOS upregulation increasing nitric oxide (L-NAME blockade confirms NO-dependence), VEGFR2 upregulation driving angiogenesis (+44% CD31+ microvessel density, abolished by anti-VEGFR2 antibody), FAK-paxillin pathway activation driving cell migration (+3852% scratch closure, abolished by FAK inhibitor), growth hormone receptor sensitisation relevant to tendon-to-bone healing, and NF-B suppression reducing TNF- and IL-6
The synthetic alternatives have the sequence of amino acids reversed and the alpha chirality changed[2]
A simple calendar for injection dates, lab appointments, and refill timing can help prevent missed doses
Available: [2] Y
